https://www.selleckchem.com/pr....oducts/1-methyl-3-ni
8%), universal red cell unit number limits (12 of 704, 1.7%), or the presence of a mixed field (3 of 704, 0.4%). This survey reveals that significant heterogeneity exists regarding the available approaches for ABO-type switching during an MTP. Specific expert guidance regarding this issue is very limited, and best practices have not yet been established or rigorously investigated. This survey reveals that significant heterogeneity exists regarding the available approaches for ABO-type switching during an MTP.